NCT03207347 2023-09-15A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)University of FloridaPhase 2 Completed37 enrolled 15 charts
NCT03497429 2021-11-09A Study of Niraparib as Single Agent in Participants With Advanced Solid TumorsTakedaPhase 1 Completed9 enrolled 24 charts